Vol. 5, n. 1, January-March 2009 1th International ... - Salute per tutti

46
F. Bruno
rash during therapy with inhibitors of epidermal grow factor
receptor (EGFR) a new clinical feature. J Plast
Dermatol 2007; 3-1:51-54.
8. Gerdes S, Mrowietz U. Follicular rash during therapy
with erlotinib (Tarceva). J Dtsch Dermatol Ges 2006;
4:855-857.
9. Pérez-Soler R, Delord JP, Halpern A et al. HER1/EGFR
inhibitor-associated rash: future directions for management
Journal of Plastic Dermatology 2009; 5, 1
and investigation outcomes from the HER1/EGFR inhibitor
rash management forum. Oncologist 2005; 10:345-56.
10. Agero AL, Dusza SW, Benvenuto-Andrade C, Busam
KJ, Myskowski P, Halpern AC. Dermatologic side effects
associated with the epidermal growth factor re c e p t o r
inhibitors. J Am Acad Dermatol 2006; 55:657-707.
11. Harrell BL, Rudolph AH. Kelp diet: a cause of acneiform
e ruption. Arch Dermatol 1976; 112:560.
Journal of Plastic Dermatology 2009; 5, 1